Patient Safety System and  Bar Code Medication Administration - IntelliDOT Investors

Investors

IntelliDOT has successfully completed more than $25 million in private equity financing since the Company's inception in 2002. We have directed investment proceeds primarily toward developing barcode medication administration technology and our new specimen collection system. Our investors include several individuals, many of whom are part of the North Bay Angels or the Sacramento Angels, as well as the following venture capital firms:


Menlo logo
Menlo Ventures is a dedicated team of investment professionals with a broad range of experience in technology, marketing, sales and general management. They have built a reputation as highly skilled and ethical investors who can help new companies define strategy, recruit the best management talent, forge industry partnerships and corporate alliances and attract investment capital. They currently focus their investments in the areas of communications, software, Internet infrastructure, semiconductors, storage and computer hardware. The firm has helped visionary leaders turn technical innovations into world-class companies since 1976. Many of these companies have become leaders in their respective markets, including LSI Logic, UUNET Technologies, Xros, Cyras Systems, Hotmail Corporation, Ascend Communications and Clarify.


American River Ventures logo
American River Ventures (ARV) is more than just an early-stage venture capital firm that invests in technology, they strive to be a partner with the entrepreneurs they invest in, helping them build great businesses. The firm’s primary market focus is on companies which provide a platform for a sustainable future through energy efficiency, energy intelligence and advanced materials. ARV brings to all of its companies its energy, vision and relationships with thought leaders and decision makers in government, corporate and university sectors.


Integral logo
Integral Capital Partners operates a family of partnerships that invests in expansion-stage private and growth-stage public companies in the information technology and life sciences industries. Since its inception in 1991, Integral has organized and managed seven funds and currently manages over $900 million in assets. With their insights and network of business development resources, Integral offers the promise of value-added investing to portfolio companies.


Shoreline Venture logo
Shoreline Venture Management, LLC is a venture capital firm based in the San Francisco Bay area. Shoreline was established in 1998 to manage Shoreline Venture Partners Funds (SVP I and SVP II) as well as future investments. SVP are diversified funds invested primarily in early-stage businesses in information technology and healthcare. Shoreline's directors have a combined 70 years of experience in operations, startup investing and deal origination, and have been investing in early-stage companies for over 15 years.


Psilos Group logo
Psilos Group invests nationwide in the healthcare services, healthcare information technology, medical device and diagnostic sectors, seeking firms that are poised to establish enduring market value by developing fundamental improvements in the healthcare system. Psilos invests in mid-late stage companies that have demonstrated an ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has been a successful healthcare venture capital firm since its founding in 1998 and currently has over $575MM under management. The firm has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.


Shea Ventures logo
Shea Ventures has been investing in early-stage venture capital since 1968, and today makes investments in venture capital, private equity, and alternative assets. Based in Southern California, Shea Ventures is affiliated with Shea Homes, Shea Properties, and Shea Construction.


DIMA Ventures
DIMA Ventures is a private investment firm providing seed capital and board-level support for startup companies in the medical device and health care service markets. Dick Allen, DIMA's President, has over 40 years of experience in the healthcare field, including a ten-year stint at Baxter Healthcare to start his career. He is currently a member of the Stanford University faculty, teaching in the graduate business program. He was a co-founder and vice president of Caremark, and, for the past 20 years, has been an investor/board member for a number of privately-held healthcare companies. He is a on the board of the Juvenile Diabetes Research Foundation International and is past chairman of the board of Hoag Memorial Hospital Presbyterian.